Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.74 +0.01 (+0.14%)
As of: Aug 21, 2026 · 2:31 PM EDT

Drugs Made In America Acquisition (DMAA) Total Liabilities (2024 - 2025)

Drugs Made In America Acquisition's (DMAA) quarterly Total Liabilities came in at $7.3 million in Q4 2025, up 814.47% YoY from $795669.0 in Q4 2024, and down 1.09% on a QoQ basis from $7.4 million in Q3 2025.

Drugs Made In America Acquisition (DMAA) Total Liabilities (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 2 years of Total Liabilities data on file, last reported at $7.3 million in Q4 2025.

  • Quarterly Total Liabilities rose 814.47% year-over-year to $7.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.3 million (up 814.47% YoY) and the FY2025 annual result came in at $7.3 million, up 814.47% from the prior year.
  • Total Liabilities fell to $7.3 million in Q4 2025, from $7.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $7.4 million in Q3 2025 to a low of $795669.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 12.19 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 11.23 Mn
3 Drugs Made In America Acquisition 506.00 Mn 506.00 Mn - 18.14 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 385,932.00
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 16.42 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 20,057.00
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 12.76 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 31.85 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 34.24 Mn
10 Drugs Made In America Acquisition 215.82 Mn 215.82 Mn - 9.14 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.28 Mn
Sep 30, 2025 7.36 Mn
Jun 30, 2025 7.20 Mn
Mar 31, 2025 7.25 Mn
Dec 31, 2024 795,669.00